|
ARFGEF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.344900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.511540E-02 |
| Normal-vs-Stage2 |
3.266000E-01 |
| Normal-vs-Stage3 |
1.157700E-02 |
| Normal-vs-Stage4 |
4.029700E-04 |
| Stage1-vs-Stage2 |
3.957400E-01 |
| Stage1-vs-Stage3 |
5.448400E-01 |
| Stage1-vs-Stage4 |
4.885500E-02 |
| Stage2-vs-Stage3 |
2.540000E-01 |
| Stage2-vs-Stage4 |
3.797600E-02 |
| Stage3-vs-Stage4 |
2.405200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.386380E-02 |
| Normal-vs-AfricanAmerican |
1.272190E-01 |
| Normal-vs-Asian |
1.103640E-02 |
| Caucasian-vs-AfricanAmerican |
8.631600E-01 |
| Caucasian-vs-Asian |
5.579400E-01 |
| AfricanAmerican-vs-Asian |
5.851800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.962100E-03 |
| Normal-vs-Female |
1.160060E-02 |
| Male-vs-Female |
5.377200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.613600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.330380E-02 |
| Normal-vs-Age(61-80Yrs) |
9.044500E-03 |
| Normal-vs-Age(81-100Yrs) |
1.386200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.878000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.864400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.931770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.690400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.111000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.992800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.204200E-01 |
| Classical-VS-Follicular |
3.323800E-01 |
| Classical-VS-Other |
1.945600E-01 |
| Classical-VS-Normal |
6.721500E-02 |
| Tall-VS-Follicular |
8.039400E-01 |
| Tall-VS-Other |
2.288800E-01 |
| Tall-VS-Normal |
8.021800E-02 |
| Follicular-VS-Other |
3.738600E-01 |
| Follicular-VS-Normal |
2.670100E-02 |
| Other-VS-Normal |
2.480000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.858400E-03 |
| Normal-vs-N1 |
6.756600E-03 |
| N0-vs-N1 |
5.526600E-01 |
|
|
